These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Analytical methods for the detection of undeclared synthetic drugs in traditional herbal medicines as adulterants. Haneef J; Shaharyar M; Husain A; Rashid M; Mishra R; Siddique NA; Pal M Drug Test Anal; 2013 Aug; 5(8):607-13. PubMed ID: 23653249 [TBL] [Abstract][Full Text] [Related]
7. Present tendencies in the adulteration and contamination of food. VALE LH J R Sanit Inst; 1953 Jan; 73(1):24-32. PubMed ID: 13011770 [No Abstract] [Full Text] [Related]
8. Tragedy, transformation, and triumph: comparing the factors and forces that led to the adoption of the 1860 Adulteration Act in England and the 1906 Pure Food and Drug Act in the United States. London J Food Drug Law J; 2014; 69(2):315-42, ii-iii. PubMed ID: 25163213 [TBL] [Abstract][Full Text] [Related]
9. [RESULTS OF TESTING LIQUID PHARMACEUTICAL PREPARATIONS FROM PHARMACIES FOR MICROBIOLOGICAL CONTAMINATION]. MEYER H Pharm Prax; 1964; 68():93-5. PubMed ID: 14240174 [No Abstract] [Full Text] [Related]
10. Protecting consumers from counterfeit drugs. FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
13. [Microbiological quality of pharmaceutical products not mandatorily sterilized]. Tagliapietra L Boll Chim Farm; 1978 Jan; 117(1):1-13. PubMed ID: 743347 [No Abstract] [Full Text] [Related]
14. [Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification?]. Schweim HG MMW Fortschr Med; 2005 Sep; 147(38):11. PubMed ID: 16218221 [No Abstract] [Full Text] [Related]
15. Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies. Bogusz MJ; Hassan H; Al-Enazi E; Ibrahim Z; Al-Tufail M J Pharm Biomed Anal; 2006 May; 41(2):554-64. PubMed ID: 16427237 [TBL] [Abstract][Full Text] [Related]
16. Control of low-level microbial contamination of drug preparations. Hess H; Knüsel F; Mullen K Pharm Acta Helv; 1969 Mar; 44(3):174-91. PubMed ID: 5790044 [No Abstract] [Full Text] [Related]
17. Microscopical contaminant monitoring. I. Particulate matter as viewed by the FDA. Schwartzman G Bull Parenter Drug Assoc; 1977; 31(4):161-5. PubMed ID: 890178 [No Abstract] [Full Text] [Related]
18. Standardization of forensic drug analyses. Frank RS; Gunn JW J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
19. The determination of adulterants in drugs consisting of leaves. FORSDIKE JL Q J Pharm Pharmacol; 1946; 19(3):270-9. PubMed ID: 20285884 [No Abstract] [Full Text] [Related]
20. IOM report lays out a blueprint for improving regulatory systems worldwide. Mitka M JAMA; 2012 May; 307(19):2014-6. PubMed ID: 22665084 [No Abstract] [Full Text] [Related] [Next] [New Search]